A recent study by the Occupational Medicine Journal in the USA highlights the dangers for medical professionals and pharmaceutical sales representatives, who often log significant mileage and experience job-related pressures.
Pharmaceutical sales reps are 49% more likely to be involved in a car crash according to the journal’s research.
MasterDrive’s CEO, Eugene Herbert, attributes this increased risk to factors such as extended driving hours, time constraints and the potential for medication-induced drowsiness.
Risky driving behaviours are a primary cause of accidents among pharmaceutical reps. Herbert emphasises the importance of targeted driver training to address these issues effectively. Traditional methods like awareness campaigns and penalties have limited impact compared to hands-on training that identifies and corrects specific risky habits.
Technology, such as telematics, is crucial in identifying and addressing driver risks. Pharmaceutical companies can use this data to tailor training programmes and implement ongoing interventions to prevent accidents.
While the implementation of the Administrative Adjudication of Road Traffic Offences Act is delayed, medical professionals need to prioritise road safety now. By addressing job stressors, fostering a road safety culture and investing in appropriate training, organisations mitigate risks and protect their employees.
Source: MotorPress
